Loading...
XNASSBRA
Market cap4.05bUSD
Dec 26, Last price  
17.10USD
1D
0.12%
1Q
-7.27%
Jan 2017
-29.98%
IPO
3.64%
Name

Sabra Health Care REIT Inc

Chart & Performance

D1W1MN
XNAS:SBRA chart
P/E
294.10
P/S
6.25
EPS
0.06
Div Yield, %
6.86%
Shrs. gr., 5y
5.43%
Rev. gr., 5y
0.76%
Revenues
648m
+3.63%
8,800,00084,225,000103,170,000134,780,000183,518,000238,864,000260,526,000405,647,000623,409,000661,736,000598,569,000569,545,000624,811,000647,514,000
Net income
14m
P
7,378,00012,842,00019,513,00033,715,00046,952,00079,413,00070,276,000158,383,000279,082,00068,996,000138,417,000-113,256,000-77,605,00013,756,000
CFO
301m
-4.80%
6,600,00044,705,00056,252,00062,099,00085,337,000121,101,000176,739,000133,486,000358,543,000372,475,000354,852,000356,390,000315,733,000300,571,000
Dividend
Aug 19, 20240.3 USD/sh
Earnings
Feb 25, 2025

Profile

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (“Senior Housing - Leased”), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
URL
https://sabrahealth.com/
IPO date
Nov 06, 2010
Employees
42
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
647,514
3.63%
624,811
9.70%
569,545
-4.85%
Cost of revenue
425,804
202,187
175,870
Unusual Expense (Income)
NOPBT
221,710
422,624
393,675
NOPBT Margin
34.24%
67.64%
69.12%
Operating Taxes
2,002
1,242
1,845
Tax Rate
0.90%
0.29%
0.47%
NOPAT
219,708
421,382
391,830
Net income
13,756
-117.73%
(77,605)
-31.48%
(113,256)
-181.82%
Dividends
(277,447)
(277,157)
(262,919)
Dividend yield
8.35%
9.65%
8.86%
Proceeds from repurchase of equity
(2,682)
(9,620)
BB yield
0.08%
0.34%
Debt
Debt current
96,462
196,982
1,783,279
Long-term debt
2,384,738
2,549,018
2,444,188
Deferred revenue
2,691,277
2,587,177
Other long-term liabilities
(2,691,277)
(2,587,177)
Net debt
2,245,223
2,561,730
4,018,791
Cash flow
Cash from operating activities
300,571
315,733
356,390
CAPEX
(33,607)
Cash from investing activities
103,130
(216,248)
(336,196)
Cash from financing activities
(410,300)
(161,707)
30,140
FCF
5,761,235
2,187,646
(237,616)
Balance
Cash
41,285
49,308
111,996
Long term investments
194,692
134,962
96,680
Excess cash
203,601
153,029
180,199
Stockholders' equity
(1,692,221)
1,064,514
1,225,381
Invested Capital
6,943,423
5,607,122
7,377,085
ROIC
3.50%
6.49%
5.54%
ROCE
4.22%
7.28%
5.18%
EV
Common stock shares outstanding
232,793
230,948
219,073
Price
14.27
14.80%
12.43
-8.20%
13.54
-22.05%
Market cap
3,321,953
15.72%
2,870,682
-3.22%
2,966,249
-17.60%
EV
5,567,176
7,927,498
9,313,342
EBITDA
404,797
610,406
572,666
EV/EBITDA
13.75
12.99
16.26
Interest
112,964
105,471
98,632
Interest/NOPBT
50.95%
24.96%
25.05%